The purpose of this study is to determine the pharmacodynamics of ocular blood flow measurements with multiple drop unoprostone isopropyl administration versus placebo in subjects with dry age-related macular degeneration (AMD).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
33
1. unoprostone isopropyl (2 drops) 2. placebo (2 drops)
1. unoprostone isopropyl (3 drops) 2. placebo (3 drops)
Medical University of Vienna
Vienna, Austria
Change in choroidal blood flow
Time frame: In total 6 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.